The U.S. Food and Drug Administration (FDA) will be continuing its enforcement discretion policy for compliance with certain FDA Food Safety Modernization Act (FSMA) supply chain program requirements applicable to receiving facilities that are co-manufacturers.

Three of the rules created to implement FSMA—Preventive Controls for Human Foods, Preventive Controls for Animal Food, and the Foreign Supplier Verification Programs—require co-manufacturers that are receiving facilities and/or importers that produce food for the brand owners to approve suppliers and conduct certain supplier verification activities. These requirements are designed to ensure suppliers are addressing hazards requiring a supply-chain-applied control.

Previously, industry expressed concerns that in some situations the supply chain requirements could conflict with existing contracts between brand owners and the firms the brand owners select to supply their co-manufacturers. To comply with the supply chain program requirements, co-manufacturers often need detailed information about suppliers that only the brand owner has, and that can’t be shared because of confidentiality clauses in the contracts between brand owners and the co-manufacturers’ suppliers.

In November 2017, the FDA announced an enforcement discretion policy until Nov. 6, 2019, for compliance with certain supply chain program requirements related to supplier approval and supplier verification. The enforcement discretion was intended to give brand owners more time to work with suppliers to adjust contracts so that supply chain related information could be shared with co-manufacturers.

Since that time, the FDA has learned of additional challenges industry is facing in trying to meet the supply chain requirements. The FDA will continue its enforcement discretion policy while advancing its work with stakeholders to better understand these challenges and to consider possible solutions to address these situations. The agency intends to announce the extension in a forthcoming notice in the Federal Register.

Press release

More News right arrow

FDA amends its procedures for dairy, infant formula firms exporting to China

The U.S. Food and Drug Administration (FDA) is announcing changes to its export listing procedures for dairy and infant formula firms seeking to export their products to China.

FDA amends its procedures for dairy, infant formula firms exporting to China

The U.S. Food and Drug Administration (FDA) is announcing changes to its export listing procedures for dairy and infant formula firms seeking to export their products to China.

FDA announces qualified health claim for cranberry products and urinary tract infections

The U.S. FDA has announced in a letter of enforcement discretion that it does not intend to object to the use of certain qualified health claims regarding consuming certain cranberry products and a reduced risk of recurrent urinary tract infection in healthy women.

FDA announces qualified health claim for cranberry products and urinary tract infections

The U.S. FDA has announced in a letter of enforcement discretion that it does not intend to object to the use of certain qualified health claims regarding consuming certain cranberry products and a reduced risk of recurrent urinary tract infection in healthy women.

EFSA seeks public comment on nutrient assessment framework

The European Food Safety Authority (EFSA) has released a draft approach that aims to harmonize assessments of the intake of these nutrients, the potentially hazardous properties of excessive intakes, and the overall risks for consumers.

IFT Weekly Newsletter

Rich in industry news and highlights, the Weekly Newsletter delivers the goods in to your inbox every Wednesday.

Subscribe for free